» Articles » PMID: 20651158

Activation of NFAT Signaling in Podocytes Causes Glomerulosclerosis

Overview
Specialty Nephrology
Date 2010 Jul 24
PMID 20651158
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Mutant forms of TRPC6 can activate NFAT-dependent transcription in vitro via calcium influx and activation of calcineurin. The same TRPC6 mutants can cause FSGS, but whether this involves an NFAT-dependent mechanism is unknown. Here, we generated mice that allow conditional induction of NFATc1. Mice with NFAT activation in nascent podocytes in utero developed proteinuria and glomerulosclerosis postnatally, resembling FSGS. NFAT activation in adult mice also caused progressive proteinuria and FSGS. Ultrastructural studies revealed podocyte foot process effacement and deposition of extracellular matrix. NFAT activation did not initially affect expression of podocin, synaptopodin, and nephrin but reduced their expression as glomerular injury progressed. In contrast, we observed upregulation of Wnt6 and Fzd9 in the mutant glomeruli before the onset of significant proteinuria, suggesting a potential role for Wnt signaling in the pathogenesis of NFAT-induced podocyte injury and FSGS. These results provide in vivo evidence for the involvement of NFAT signaling in podocytes, proteinuria, and glomerulosclerosis. Furthermore, this study suggests that NFAT activation may be a key intermediate step in the pathogenesis of mutant TRPC6-mediated FSGS and that suppression of NFAT activity may contribute to the antiproteinuric effects of calcineurin inhibitors.

Citing Articles

The Ca-actin-cytoskeleton axis in podocytes is an important, non-immunologic target of immunosuppressive therapy in proteinuric kidney diseases.

Hackl A, Weber L Pediatr Nephrol. 2025; .

PMID: 39856247 DOI: 10.1007/s00467-025-06670-z.


Dysregulation of Podocyte BK Channels and Nephrosis: Effects of Circulating Factors and Auxiliary β4 Subunits.

Kim E, Rachubik P, Dryer S Cells. 2025; 14(1.

PMID: 39791723 PMC: 11719602. DOI: 10.3390/cells14010022.


Endothelial eNOS deficiency causes podocyte injury through NFAT2 and heparanase in diabetic mice.

Katagiri D, Nagasaka S, Takahashi K, Wang S, Pozzi A, Zent R Sci Rep. 2024; 14(1):29179.

PMID: 39587144 PMC: 11589149. DOI: 10.1038/s41598-024-79501-0.


Natural History and Clinicopathological Associations of TRPC6-Associated Podocytopathy.

Wooden B, Beenken A, Martinelli E, Saida K, Knob A, Ke J J Am Soc Nephrol. 2024; 36(2):274-289.

PMID: 39352759 PMC: 11801752. DOI: 10.1681/ASN.0000000501.


Long-term outcomes in rapamycin on renal allograft function: a 30-year follow-up from a single-center experience.

Ji Y, Sun L, Fei S, Gao X, Chen H, Han Z BMC Nephrol. 2024; 25(1):311.

PMID: 39294598 PMC: 11411783. DOI: 10.1186/s12882-024-03730-8.


References
1.
Petermann A, Krofft R, Blonski M, Hiromura K, Vaughn M, Pichler R . Podocytes that detach in experimental membranous nephropathy are viable. Kidney Int. 2003; 64(4):1222-31. DOI: 10.1046/j.1523-1755.2003.00217.x. View

2.
Woroniecki R, Kopp J . Genetics of focal segmental glomerulosclerosis. Pediatr Nephrol. 2007; 22(5):638-44. PMC: 2467504. DOI: 10.1007/s00467-007-0445-y. View

3.
Barisoni L, Schnaper H, Kopp J . Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy. Arch Pathol Lab Med. 2009; 133(2):201-16. PMC: 3118840. DOI: 10.5858/133.2.201. View

4.
Plank C, Kalb V, Hinkes B, Hildebrandt F, Gefeller O, Rascher W . Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie. Pediatr Nephrol. 2008; 23(9):1483-93. PMC: 2730636. DOI: 10.1007/s00467-008-0794-1. View

5.
Vogelmann S, Nelson W, Myers B, Lemley K . Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol. 2003; 285(1):F40-8. PMC: 3368602. DOI: 10.1152/ajprenal.00404.2002. View